跳至主要内容
临床试验/NCT02680483
NCT02680483终止不适用

Atrial Fibrillation Registry in Jordan

Jordan Collaborating Cardiology Group1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2016年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
2,000
试验地点
1
主要终点
Incidence of stroke and systemic embolization and cardiovascular death

研究概览

简要总结

Prospective registry of all new comers with Atrial fibrillation

详细描述

12 tertiary care centers will enroll all AF comers. Details of baseline clinical, EKG, echo, and lab data will be documented for all patients. Management is according to the physicians discretion. Patients will be followed up for 1 year for clinical endpoints including cardiovascular death, stroke, heart failure, systemic embolization and bleeding.. Anticoagulants and other cardiovascular medications will also be documented.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission with atrial fibrillation
  • developing atrial fibrillation during hospitalization for mon AF reason.
  • age 18 or more years.
  • patients welling to participate in the registry.

排除标准

  • age less than 18 years.
  • patients not welling to participate.

结局指标

主要结局

Incidence of stroke and systemic embolization and cardiovascular death

时间窗: 1 year

all ischemic and hemorrhagic strokes and embolization to any arterial bed during follow up period

次要结局

  • Number of readmission for atrial fibrillation(1 year)
  • Number of readmission for other cardiovascular events(1 year)

研究者

发起方
Jordan Collaborating Cardiology Group
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayman J Hammoudeh, MD, FACC

Co- investigator with Munir Zaqqa, MD, FACC

Jordan Collaborating Cardiology Group

研究点 (1)

Loading locations...

相似试验